SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
HALOZYME THERAPEUTICS
(NQNM:HALO Last Sale: 23.85 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (HALO : $23.85)
$3,292,955 million Market Cap at Market Close, July 1, 2022
Employs 40.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
11588 Sorrento Valley Road, Suite 17 Research Report Earnings Snapshot - Last 11/10/18
San Diego, CA 92121 Fact Sheet
Phone: (858) 794-8889 Financial Statements
Peer Comparison
Annual Reports

Jonathan E. Lim, Pres./CEO, David A. Ramsay, CFO
Transfer to Nasdaq after raising $32.1 million in a private placement, with sale of 3.5 million shares at $9.17. Transfer to Amex from (OTCBB: HZYM), November 1, 2004. Formerly, GLOBAL YACHT SERVICES INC. Closely-held by New River Management V LP, a private equity fund managed by Third Security LLC, affiliated with Randal J. Kirk.
Historical Charts    Technical Analysis
No Historical Data available for HALO

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common HALO $23.85 $23.85 0 .0 $22.79 $24.49 2,065,143 $22.79 $24.49 138,069,410
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock #############

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
09-MAY-07 HTI Symbol Changed to HALO

A74
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex